1-3 of 3
Marie-Luise Hütter
Close
Sort by
Journal Articles

Interim Results of a Phase I/II Clinical Trial of Belinostat in Combination with Idarubicin in Patients with AML Not Suitable for Standard Intensive Therapy.

Richard Schlenk, Kristina Sohlbach, Marie-Luise Hütter, Patrice Ceballos, Nathalie Fegueux, MD, Emmanuel Raffoux, Herve Dombret, MD, Mike Dennis, Jo Tomlins, Jette Tjørnelund, Andreas Neubauer
Journal: Blood
Blood (2008) 112 (11): 1953.
https://doi.org/10.1182/blood.V112.11.1953.1953
Published: 2008
Journal Articles

Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies

Anne Sonet, Carlos Graux, Johan Maertens, Christine-Maria Hartog, Justus Duyster, Katharina Götze, Jochen Greiner, Marie-Luise Hütter, Alois Gratwohl, Dominik Heim, Dagmar Hess, Yves Chalandon, Athos Gianella-Borradori, Narmyn Rejeb, Oliver Ottmann
Journal: Blood
Blood (2008) 112 (11): 2963.
https://doi.org/10.1182/blood.V112.11.2963.2963
Published: 2008
Journal Articles

Role of Etoposide in Combination with All- Trans Retinoic Acid in the Treatment of Elderly Patients with Acute Myeloid Leukemia and NPM1 Mutation

Marie-Luise Hütter, Konstanze Döhner, Ingo G.H. Schmidt-Wolf, Francisco Del Valle, Björn Heydrich, Wolfgang Heit, Walter Fiedler, Michael Pfreundschuh, MD, PhD, Gudrun Russ, Martin Bentz, Aruna Raghavachar, Detlef Haase, MD, PhD, Wolfram Brugger, MD, Katharina Götze, Silja Groner, Hartmut Döhner, Richard Schlenk
Journal: Blood
Blood (2008) 112 (11): 559.
https://doi.org/10.1182/blood.V112.11.559.559
Published: 2008